65,437 trials
Myelodysplastic Syndromes · Secondary Acute Myeloid Leukemia
Primary: Maximum Tolerated Dose of CD8 Depleted Non-engrafting HLA-mismatched Unrelated Donor Lymphocytes Infusion (NE-DLI) — 5 10^7 CD4 cells/kg
Non-alcoholic Steatohepatitis · Hepatic Impairment
Primary: Area Under the Curve From Time 0 to Infinity (AUC0-inf) of Efinopegdutide — 143; 152; 146 hr*μg/mL
Gastroenteritis
Primary: Percentage of Participants With Seroconversion for Anti-poliovirus Types 1, 2 and 3 Neutralizing Antibody (Ab) — 99.2; 99.3; 100; 99.3 Percentage of participants
Congenital Adrenal Hyperplasia · CAH - Congenital Adrenal Hyperplasia
Primary: Safety of SPR001 in Patients With CAH — 6; 5; 4 Participants
HIV-1-infection
Primary: Safety of TMB-365 and TMB-380 Given Intravenously (Sentinel and Core) — 0; 0; 0; 0 Participants
Small Cell Lung Cancer
Primary: Investigator-assessed Progression-free Survival (PFS) in the Primary Analysis Set (PAS) — 5.55; 5.36 months — p=0.3504
Acute Coronary Syndrome · Myocardial Infarction
Primary: Number of Participants Who Are Successfully Enrolled Into the Pilot Study Per Month — 0.91 Participants enrolled per month
Prader-Willi Syndrome
Primary: Excessive Daytime Sleepiness — -3.5; -5.0; -3.9 score on a scale
Lateral Patient Transfer
Primary: Time to Complete Lateral Transfer — 33.40; 4.094 minutes
ALK Gene Mutation · BRAF Gene Mutation · EGFR Gene Mutation
Primary: Overall Response Rate (ORR) — 6; 3 Participants
Opioid-use Disorder · Tobacco Use Disorder
Primary: Attentional Bias for Smoking Stimuli — 501.53; 406.70 milliseconds
Skin Disorder
Primary: Bilirubin Concentration From Non-invasive Diffuse Reflectance Spectroscopy (DRS) vs BiliChek — 0.814386451; 0.85422779; 0.67588721; 0.79293382 Correlation Coefficient…
Schizophrenia
Primary: Change From Baseline to Week 4 in the PANSS Total Score — -14.28; -13.95; -16.08; -9.27 score on a scale — p=0.0009
Weight Change, Body
Primary: Change in United States Department of Agriculture (USDA) Healthy Eating Index (HEI) — 51.0; 52.6; 3.38; 0.92 units on a scale
Hiv · Tobacco Smoking
Primary: Gaze Fixation on Smoking Cues — 320.19; 152.60 milliseconds